Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIK1 | P57059 | 2/20 | 0.56 |
| ▸ | SIK2 | Q9H0K1 | 2/20 | 0.56 |
| ▸ | SIK3 | Q9Y2K2 | 2/20 | 0.56 |
| ▸ | SRC | P12931 | 10/20 | 0.53 |
| ▸ | LCK | P06239 | 2/20 | 0.50 |
| ▸ | KDR | P35968 | 2/20 | 0.50 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.50 |
| ▸ | JAK3 | P52333 | 3/20 | 0.49 |
| ▸ | BTK | Q06187 | 3/20 | 0.49 |
| ▸ | TNK2 | Q07912 | 1/20 | 0.49 |
| ▸ | HCK | P08631 | 1/20 | 0.48 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.48 |
| ▸ | EGFR | P00533 | 4/20 | 0.48 |
| ▸ | ITK | Q08881 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4496222 | 1.00 | SIK1 (0.56) | SIK1SIK2SIK3SRCLCK | |
| SCHEMBL4559474 | 0.94 | TNK2 (0.55) | SIK1SIK2SIK3SRCLCK | |
| SCHEMBL4502869 | 0.89 | LCK (0.51) | SIK1SIK2SIK3SRCLCK | |
| SCHEMBL4498890 | 0.88 | LCK (0.52) | SIK1SIK2SIK3SRCLCK | |
| SCHEMBL4488130 | 0.87 | LCK (0.51) | SIK1SIK2SIK3SRCLCK | |
| SCHEMBL4489722 | 0.86 | LCK (0.53) | SIK1SIK2SIK3SRCLCK | |
| SCHEMBL4480780 | 0.86 | LCK (0.61) | SIK1SIK2SIK3SRCLCK | |
| SCHEMBL4484358 | 0.86 | LCK (0.51) | SIK1SIK2SIK3SRCLCK | |
| SCHEMBL4489811 | 0.86 | LCK (0.56) | SIK1SIK2SIK3SRCLCK | |
| SCHEMBL4501143 | 0.86 | SIK1 (0.48) | SIK1SIK2SIK3SRCLCK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7504396-B2 | Substituted heterocyclic compounds and methods of use | AMGEN INC. (US) | 2009-03-17 | — | — | US | disclosed |